This content is machine translated Rivastigmine Dosage is critical with cholinesterase inhibitors Background: Alzheimer’s disease (AK) is the most common cause of dementia. The pathophysiology is complex and includes reductions in neurotransmitter release, leading to cognitive and functional impairment.
